Aids Update

Guests: Dr. Robert Doms Assistant Professor of Pathology and Laboratory Medicine University of Pennsylvania Philadelphia, Pennsylvania Dr. H. Clifford Lane Clinical Director National Institute of Allergy and Infectious Diseases National Institutes of Health Bethesda, Maryland Dr. Robert Gallo Professor and Director Institute of Human Virology University of Maryland Baltimore, Maryland This week, articles in two scientific journals report that certain molecules may block some of the receptors needed for HIV infection. This could translate into new ways to treat or prevent AIDS infection. This comes after news that the number of new AIDS cases diagnosed in the U.S. has dropped for the first time since the discovery of the disease, and that the number of AIDS deaths in this country dropped 23 per cent from 1995 to 1996. But while there may be cause for optimism, there is still a long way to go. Join Ira Flatow in this hour of Science Friday for an AIDS update.

Copyright © 1997 NPR. For personal, noncommercial use only. See Terms of Use. For other uses, prior permission required.

Copyright © 1997 NPR. All rights reserved. No quotes from the materials contained herein may be used in any media without attribution to NPR. This transcript is provided for personal, noncommercial use only, pursuant to our Terms of Use. Any other use requires NPR's prior permission. Visit our permissions page for further information.

NPR transcripts are created on a rush deadline by a contractor for NPR, and accuracy and availability may vary. This text may not be in its final form and may be updated or revised in the future. Please be aware that the authoritative record of NPR's programming is the audio.



Please keep your community civil. All comments must follow the Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.